Castle Rock Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $288K | Sell |
1,549
-3,534
| -70% | -$657K | 0.07% | 213 |
|
2025
Q1 | $1.06M | Sell |
5,083
-2,055
| -29% | -$427K | 0.29% | 95 |
|
2024
Q4 | $1.38M | Buy |
7,138
+341
| +5% | +$65.8K | 0.33% | 87 |
|
2024
Q3 | $1.32M | Buy |
6,797
+119
| +2% | +$23.1K | 0.32% | 90 |
|
2024
Q2 | $1.14M | Buy |
6,678
+205
| +3% | +$34.9K | 0.28% | 100 |
|
2024
Q1 | $1.05M | Buy |
6,473
+431
| +7% | +$69.7K | 0.29% | 106 |
|
2023
Q4 | $977K | Sell |
6,042
-47
| -0.8% | -$7.6K | 0.3% | 91 |
|
2023
Q3 | $905K | Buy |
6,089
+2,511
| +70% | +$373K | 0.3% | 83 |
|
2023
Q2 | $492K | Buy |
3,578
+194
| +6% | +$26.7K | 0.17% | 128 |
|
2023
Q1 | $497K | Buy |
3,384
+15
| +0.4% | +$2.2K | 0.18% | 125 |
|
2022
Q4 | $497K | Sell |
3,369
-196
| -5% | -$28.9K | 0.22% | 122 |
|
2022
Q3 | $504K | Buy |
+3,565
| New | +$504K | 0.25% | 106 |
|
2020
Q3 | – | Sell |
-6,029
| Closed | -$569K | – | 163 |
|
2020
Q2 | $569K | Buy |
6,029
+1,757
| +41% | +$166K | 0.33% | 103 |
|
2020
Q1 | $384K | Sell |
4,272
-4,797
| -53% | -$431K | 0.33% | 79 |
|
2019
Q4 | $871K | Buy |
9,069
+751
| +9% | +$72.1K | 0.78% | 40 |
|
2019
Q3 | $713K | Buy |
8,318
+866
| +12% | +$74.2K | 0.74% | 42 |
|
2019
Q2 | $545K | Buy |
+7,452
| New | +$545K | 0.6% | 60 |
|
2018
Q4 | – | Sell |
-4,719
| Closed | -$395K | – | 10 |
|
2018
Q3 | $395K | Sell |
4,719
-30
| -0.6% | -$2.51K | 0.63% | 54 |
|
2018
Q2 | $440K | Buy |
4,749
+791
| +20% | +$73.3K | 0.6% | 63 |
|
2018
Q1 | $375K | Sell |
3,958
-1,153
| -23% | -$109K | 0.62% | 57 |
|
2017
Q4 | $494K | Buy |
+5,111
| New | +$494K | 0.96% | 36 |
|